Granite Harbor Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
Granite Harbor Advisors's PFE Position: Q2 2026 in Review
Granite Harbor Advisors increased its Pfizer (PFE) stake by 10% in Q2 2026, buying an estimated $52.9K and bringing the position to 21,404 shares worth $515K. The position accounts for 0.2% of the portfolio, ranked #80.
Granite Harbor Advisors first reported a position in PFE in Q3 2024 and has held it in 7 quarters since. The position peaked at $544K in Q1 2026. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Granite Harbor Advisors held 21,404 shares of Pfizer worth $515K as of Q2 2026.
- Granite Harbor Advisors bought 2,024 Pfizer shares in Q2 2026, an estimated $52.9K.
- Pfizer made up 0.2% of Granite Harbor Advisors's portfolio in Q2 2026, its #80 holding.
- Granite Harbor Advisors first reported a position in Pfizer in Q3 2024 and has held it in 7 quarters since.
- Granite Harbor Advisors's Pfizer position peaked at $544K in Q1 2026.
- 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Granite Harbor Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.